Table 2 Baseline characteristics of pregnancies according to diagnosis of LR asymmetry disorders.
Characteristic | LR asymmetry disorders Fetuses (n = 30) | Normal Fetuses (n = 30) | P |
---|---|---|---|
Maternal Age | 28.93 ± 4.91 | 30.97 ± 4.91 | 0.11 |
GA of confirmed LR asymmetry disorders | 22.3 ± 4.2 | 22.33 ± 4.37 | 0.98 |
Previous pregnancies | Â | Â | 0.19 |
None | 16/30(53.33%) | 12/30(40%) | Â |
1–2 | 9/30(30%) | 16/30(53.33%) |  |
3 +  | 5/30(16.67%) | 2/30(6.67%) |  |
SARS-CoV-2 | Â | Â | 0.026* |
Negative | 1/30(3.33%) | 8/30(26.67%) | Â |
Positive | 29/30(96.67%) | 22/30(73.33%) | Â |
Symptoms | Â | Â | Â |
Fever | 28/29(96.55%) | 21/22(95.45%) | 1.0 |
Asthenia | 11/29(37.93%) | 7/22(31.81%) | 0.77 |
Dyspnea | 0 | 0 | - |
Cough | 20/29(68.97%) | 9/22(40.91%) | 0.05 |
HNT symptoms | 17/29(58.62%) | 11/22(50%) | 0.58 |
Headache | 12/29(41.38%) | 5/22(22.73%) | 0.23 |
Myalgia | 17/29(58.62%) | 10/22(45.45%) | 0.41 |
Trimester of infection | Â | Â | 0.008* |
I | 28/29(96.55%) | 15/22(68.18%) | Â |
II | 1/29(3.45%) | 3/22(13.64%) | Â |
III | 0 | 4/22(18.18%) | Â |
Vaccination completed | Â | Â | 0.68 |
None | 6/30(20%) | 4/30(13.33%) | Â |
1 | 2/30(6.67%) | 1/30(3.33%) | Â |
2 | 3/30(10%) | 6/30(20%) | Â |
3 | 19/30(63.33%) | 19/30(63.33%) | Â |
Chromosome | Â | Â | 1.0 |
Normal | 29/30(96.67%) | 30/30(100%) | Â |
Abnormal | 1/30(3.33%) | 0 | Â |
Family History |  |  | – |
Yes | 0 | 0 | Â |
No | 30/30(100%) | 30/30(100%) | Â |